Literature DB >> 2899403

Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia.

G W Arana1, D C Goff, R J Baldessarini, G A Keepers.   

Abstract

The authors analyzed data from nine studies comparing the incidence of acute dystonia induced by neuroleptic agents with and without concomitant use of anticholinergic agents. Anticholinergic agents reduced the rate of dystonia by 1.9-fold in all patients treated with different neuroleptics and by 5- to 8-fold in patients treated with high-potency neuroleptics. In addition, the incidence of dystonia and the efficacy of anticholinergic prophylaxis were related inversely to age. These results support the efficacy of anticholinergic agents in preventing neuroleptic-induced dystonia, particularly in young male patients treated with high-potency neuroleptics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899403     DOI: 10.1176/ajp.145.8.993

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  14 in total

Review 1.  Acute dystonia induced by drug treatment.

Authors:  P N van Harten; H W Hoek; R S Kahn
Journal:  BMJ       Date:  1999-09-04

2.  Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial.

Authors:  Stanley N Caroff; Irene Hurford; Janice Lybrand; E Cabrina Campbell
Journal:  Neurol Clin       Date:  2011-02       Impact factor: 3.806

3.  Prophylaxis of antipsychotic drug-induced extrapyramidal syndromes.

Authors:  G A Keepers
Journal:  West J Med       Date:  1991-11

4.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

5.  Frequency of Extrapyramidal Adverse Reactions in Schizophrenic Outpatients Treated with Risperidone, Olanzapine, Quetiapine or Haloperidol : Results of the EIRE Study.

Authors:  Julio Bobes; J Rejas; M Garcia-Garcia; F Rico-Villademoros; M P García-Portilla; M Madrigal; G Hernández
Journal:  Clin Drug Investig       Date:  2002-09       Impact factor: 2.859

6.  Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine.

Authors:  A Campbell; R J Baldessarini; J L Neumeyer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 7.  Pitfalls and problems of the long term use of neuroleptic drugs in schizophrenia.

Authors:  M F Bristow; S R Hirsch
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 8.  A clinical guide to antipsychotic drugs.

Authors:  J T Schwartz; A W Brotman
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

9.  Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth.

Authors:  Tamara Pringsheim; Asif Doja; Stacey Belanger; Scott Patten
Journal:  Paediatr Child Health       Date:  2011-11       Impact factor: 2.253

10.  [Not Available].

Authors:  Tamara Pringsheim; Asif Doja; Stacey Belanger; Scott Patten
Journal:  Paediatr Child Health       Date:  2012-10       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.